Literature DB >> 23572151

Comparison of immunosuppressive and immunomodulatory cells in keratoacanthoma and cutaneous squamous cell carcinoma.

Yumi Kambayashi1, Taku Fujimura, Setsuya Aiba.   

Abstract

An imbalance of immunosuppressive and immunomodulatory cells plays an important role in inhibiting the anti-tumour immune response in a tumour-bearing host. Among such cells, regulatory T cells (Tregs), together with immunosuppressive macrophages, such as CD163+ M2 macrophages, play roles in maintaining the tumour microenvironment. In contrast, interleukin-27 (IL-27) induces STAT1 and STAT3 activation, thus resulting in the enhancement of naive CD4 T-cell proliferation, the promotion of early Th1 differentiation, and the induction of the anti-tumour immune response. The purpose of this study was to investigate the involvement of immunosuppressive cells, such as Tregs and CD163+ macrophages, as well as immunomodulatory cells (i.e. IL-27-producing cells) in keratoacanthoma (KA) and invasive squamous cell carcinoma (SCC). We also examined the presence of CD3+ Foxp3+ Tregs cells in lesional skin from 10 patients with KA and 18 patients with SCC. Increased numbers of CD3+ Foxp3+ Tregs were observed in SCC compared with KA. In parallel with Tregs, higher numbers of CD163+ macrophages and MMP-9+ cells were detected only in SCC. In contrast, IL-27-producing cells were increased only in KA. In addition, the expression of pSTAT1 on tumour cells was observed only in KA. These findings suggest that the induction of immunosuppressive and immunomodulatory cells differs between KA and SCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572151     DOI: 10.2340/00015555-1597

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  16 in total

Review 1.  [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].

Authors:  M Majores; E Bierhoff
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 2.  Update of the Management of Cutaneous Squamous-cell Carcinoma.

Authors:  Eve Maubec
Journal:  Acta Derm Venereol       Date:  2020-06-03       Impact factor: 3.875

3.  Immunomodulatory effect of bisphosphonate risedronate sodium on CD163+ arginase 1+ M2 macrophages: the development of a possible supportive therapy for angiosarcoma.

Authors:  Taku Fujimura; Yumi Kambayashi; Sadanori Furudate; Aya Kakizaki; Setsuya Aiba
Journal:  Clin Dev Immunol       Date:  2013-12-09

4.  Keratoacanthoma accompanied by multiple lung squamous cell carcinomas developing in a renal transplant recipient.

Authors:  Sadanori Furudate; Taku Fujimura; Aya Kakizaki; Yumi Kambayashi; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2014-07-09

5.  M2-Polarized Macrophages Compose Lupus Vulgaris Arising from a Bacillus Calmette-Guérin Vaccination Site.

Authors:  Yota Sato; Taku Fujimura; Sadanori Furudate; Aya Kakizaki; Osamu Iizawa; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2016-07-19

6.  Recurrent Multiple Squamous Cell Carcinomas on the Scalp in a Patient with Juvenile Dermatomyositis.

Authors:  Yota Sato; Taku Fujimura; Yumi Kambayashi; Akira Tsukada; Takanori Hidaka; Kayo Tanita; Takahiro Haga; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Oncol       Date:  2017-01-20

7.  Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.

Authors:  Taku Fujimura; Sadanori Furudate; Yumi Kambayashi; Setsuya Aiba
Journal:  Clin Dev Immunol       Date:  2013-03-31

Review 8.  Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Authors:  Taku Fujimura; Yumi Kambayashi; Yasuhiro Fujisawa; Takanori Hidaka; Setsuya Aiba
Journal:  Front Oncol       Date:  2018-01-23       Impact factor: 6.244

9.  Keratoacanthoma Centrifugum Marginatum with Spontaneous Regression and Its Possible Differential Diagnosis.

Authors:  Ryo Amagai; Taku Fujimura; Yumi Kambayashi; Sadanori Furudate; Yota Sato; Kayo Tanita; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Oncol       Date:  2018-10-24

10.  Keratoacanthoma of the Lip: Activation of the mTOR Pathway, Tumor Suppressor Proteins, and Tumor Senescence.

Authors:  Caroline Siviero Dillenburg; Manoela Domingues Martins; Luise Meurer; Rogerio Moraes Castilho; Cristiane Helena Squarize
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.